NSF, a global public health and safety organization, has acquired Cambium Analytica, a provider of analytical testing and development services for the natural food, beverage, and dietary supplement industries.
With the addition of Cambium Analytica, NSF is better-positioned to meet accelerating client demands by offering access to integrated, best-in-class solutions at scale. The acquisition bridges critical gaps in the natural products market. Cambium Analytica’s timely in-process QA and batch release testing, contract research, and product development services will integrate seamlessly with NSF’s audit-focused certification programs, offering clients complete support from concept through market compliance.
“By integrating Cambium Analytica’s cutting-edge operations with NSF’s eight decades of leadership in safety and testing, we continue to strengthen our position as the partner of choice for clients across the food and nutrition industries,” said Pedro Sancha, President and CEO of NSF.
“This partnership represents the perfect alignment of Cambium Analytica’s innovative, customer-centric approach with NSF’s long-established excellence in public health and safety,” said Alex Adams, CEO of Cambium Analytica. “Together, we’re positioned to lead the next wave of growth in the rapidly evolving consumer products industry – uniting disruptive agility and deep scientific expertise to create an innovative, new testing and inspection ecosystem.”
NSF is a global public health and safety organization dedicated to improving human and planet health through standards development, testing, inspection, certification, and advisory services for the food, nutrition, water, life sciences, and consumer goods industries.
EC M&A acted as the exclusive financial advisor to NSF on this transaction.